menu
{ "item_title" : "Toxicity and Drug Testing", "item_author" : [" Bill Acree "], "item_description" : "Modern drug design and testing involves experimental in vivo and in vitro measurement of the drug candidate's ADMET (adsorption, distribution, metabolism, elimination and toxicity) properties in the early stages of drug discovery. Only a small percentage of the proposed drug candidates receive government approval and reach the market place. Unfavorable pharmacokinetic properties, poor bioavailability and efficacy, low solubility, adverse side effects and toxicity concerns account for many of the drug failures encountered in the pharmaceutical industry. Authors from several countries have contributed chapters detailing regulatory policies, pharmaceutical concerns and clinical practices in their respective countries with the expectation that the open exchange of scientific results and ideas presented in this book will lead to improved pharmaceutical products.", "item_img_path" : "https://covers2.booksamillion.com/covers/bam/9/53/510/004/9535100041_b.jpg", "price_data" : { "retail_price" : "205.00", "online_price" : "205.00", "our_price" : "205.00", "club_price" : "205.00", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
Toxicity and Drug Testing|Bill Acree

Toxicity and Drug Testing

local_shippingShip to Me
In Stock.
FREE Shipping for Club Members help

Overview

Modern drug design and testing involves experimental in vivo and in vitro measurement of the drug candidate's ADMET (adsorption, distribution, metabolism, elimination and toxicity) properties in the early stages of drug discovery. Only a small percentage of the proposed drug candidates receive government approval and reach the market place. Unfavorable pharmacokinetic properties, poor bioavailability and efficacy, low solubility, adverse side effects and toxicity concerns account for many of the drug failures encountered in the pharmaceutical industry. Authors from several countries have contributed chapters detailing regulatory policies, pharmaceutical concerns and clinical practices in their respective countries with the expectation that the open exchange of scientific results and ideas presented in this book will lead to improved pharmaceutical products.

This item is Non-Returnable

Details

  • ISBN-13: 9789535100041
  • ISBN-10: 9535100041
  • Publisher: Intechopen
  • Publish Date: February 2012
  • Dimensions: 9.61 x 6.69 x 1.13 inches
  • Shipping Weight: 2.29 pounds
  • Page Count: 532

Related Categories

You May Also Like...

    1

BAM Customer Reviews